Balentine LLC’s Dynavax Technologies DVAX Stock Holding History

Balentine LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-554	Closed	-$8K	–	456
2016 Q2	$8K	Buy	+554	New	+$9.47K	﹤0.01%	372

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Balentine LLC's DVAX Position: Q3 2016 in Review

Balentine LLC sold out of Dynavax Technologies (DVAX) in Q3 2016, closing a stake of 554 shares — an estimated $8K sold.

Balentine LLC first reported a position in DVAX in Q2 2016 and held it in 1 quarter. The position peaked at $8K in Q2 2016. 122 funds tracked by Wall St. Rank hold DVAX as of Q3 2016.

Balentine LLC reported no remaining Dynavax Technologies position as of Q3 2016 after selling out during the quarter.
Balentine LLC sold 554 Dynavax Technologies shares in Q3 2016, an estimated $8K.
Balentine LLC first reported a position in Dynavax Technologies in Q2 2016 and held it in 1 quarter.
Balentine LLC's Dynavax Technologies position peaked at $8K in Q2 2016.
122 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2016.

Based on Balentine LLC's 13F filing for Q3 2016, filed 15 Nov 2016.